Skip to main content
OpenTrials
Completed

NCT Number: NCT01148706

Effectiveness of ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided Procedures

To assist in guiding a rigid interventional instrument percutaneously, to a designated point within the body by means of CT visualization.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Carmel Medical Center

Haifa, Israel

About this study

The ActiSight™ Needle Guidance System is an optical navigation system designed to assist physicians performing percutaneous interventions under CT guidance. The system allows the user to select an obstacle free path to a target lesion based on pre-procedure CT images, and then provides real-time information for guiding the interventional tool towards the target along the selected path.

The ActiSight™ Needle Guidance System employs a miniature video camera mounted on the needle and a reference pad attached to the skin to register the needle into the CT image space, and thus, track the needle advance towards the target. CT scans are used as needed to verify the location of the needle.

The primary objective of this study is to demonstrate the effectiveness of the ActiSight™ Needle Guidance System in assisting in CT-guided percutaneous procedures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects, 18 years of age or older at the time of enrollment.
  • Subjects meeting all medical conditions for percutaneous CT guided. procedures in the chest, abdomen or pelvic, with safe path to lesion.
  • Written informed consent to participate in the study.
  • Ability to comply with the requirements of the study procedures.

Exclusion criteria

  • Having co-morbidities that would clinically preclude them from an image guided procedure as determined by the operating physician.
  • Significant coagulopathy that cannot be adequately corrected.
  • Patients who have a medical contraindication to sedation (Lidocaine allergy).
  • Pregnancy or lactation.
  • Participation in an investigational trial within 30 days of enrollment.

Treatment and study plan

ActiSight Needle Guidance System

Device

The ActiSight™ Needle Guidance System employs a miniature video camera mounted on the needle and a reference pad attached to the skin to register the needle into the CT image space, and thus, track the needle advance towards the target. CT scans are used as needed to verify the location of the needle.

Other names: ASNG=ActiSight Needle Guidance System

Primary outcomes

  1. Number of CT scans performed during the procedure, from needle insertion to final needle position in the target lesion

    Time frame: 1 Hour- During the procedure

Secondary outcomes

  1. Procedure time (needle dwell time in the body)

    Time frame: 1 hour -duration of the procedure

Sponsors and collaborators

Lead sponsor

ActiViews Ltd.

Industry

Registry information

Official study title

Phase IV Study of the ActiSight Needle Guidance System Which Assist in Guiding a Rigid Interventional Instrument Percutaneously, to a Designated Point Within the Body by Means of CT Visualization

Acronym: ASNG

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Jun 22, 2010
Registry last updated
Dec 11, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.